Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives (Q26799767)

Giuseppe Lopalco

2

0 references

Florenzo Iannone

Florenzo Iannone

3

0 references

Luca Cantarini

Luca Cantarini

8

0 references

Giovanni Lapadula

Giovanni Lapadula

7

0 references

Mauro Galeazzi

6

Mauro Galeazzi

0 references

Rosaria Talarico

5

Rosaria Talarico

0 references

Cinzia Rotondo

1

Mediators of Inflammation

Cinzia Rotondo

0 references

language of work or name

English

0 references

publication date

22 June 2015

8 references

12 March 2019

13 March 2019

21 March 2019

22 April 2019

25 April 2019

17 June 2019

3 October 2019

21 October 2019

8 references

12 March 2019

13 March 2019

21 March 2019

22 April 2019

25 April 2019

17 June 2019

3 October 2019

21 October 2019

2015

0 references

page(s)

451675

0 references

copyright license

Creative Commons Attribution 3.0 Unported

8 references

12 March 2019

13 March 2019

21 March 2019

22 April 2019

25 April 2019

17 June 2019

3 October 2019

on focus list of Wikimedia project

21 October 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Behçet's disease: a new target for anti-tumour necrosis factor treatment

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study

7 April 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

7 April 2017

https://api.crossref.org/works/10.1155/2015/451675

A double-blind trial of colchicine in Behçet's syndrome

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Biological treatments in Behçet's disease: beyond anti-TNF therapy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Behçet's syndrome pathophysiology and potential therapeutic targets

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Current and future treatments for Behçet's uveitis: road to remission

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Monogenic autoinflammatory diseases: concept and clinical manifestations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

New insights into the pathogenesis of Behçet's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Registries in rheumatological and musculoskeletal conditions. Paediatric Behçet's disease: an international cohort study of 110 patients. One-year follow-up data

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Etiopathogenesis of Behcet's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

EULAR recommendations for the management of Behçet disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Mucocutaneous lesions of Behcet's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Behçet disease: recommendation for clinical management of mucocutaneous lesions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Behçet's disease as an autoinflammatory disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

The use of interferon alpha in Behçet disease: review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

The clinical significance of a pathergy reaction in patients with Behcet's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Behçet's disease: an update

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Interferon alfa-2a in the treatment of Behçet's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

A controlled trial of azathioprine in Behçet's syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Efficacy and safety of systemic recombinant interferon-alpha in Behçet's disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Systemic interferon alpha 2b treatment in Behçet's syndrome.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Chemiluminescence of neutrophils from patients with Behçet's disease and its correlation with an increased proportion of uncommon serotypes of Streptococcus sanguis in the oral flora

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series.

31 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F451675

Safety and efficacy of etanercept in children with juvenile-onset Behcets disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F451675

Clinical and immunological effects of azithromycin in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F451675

Effects of azithromycin on intracellular cytokine responses and mucocutaneous manifestations in Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F451675

Remission induction in Behçet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F451675

Successful treatment of genital ulcers with infliximab in Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F451675

Long-lasting remission of severe Behçet's disease after the end of infliximab therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F451675

Etanercept therapy in Behçet's disease. The tight control strategy in refractory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F451675

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F451675

Cytokines and Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F451675

Anakinra treatment in drug-resistant Behcet’s disease: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F451675

Development of de novo major involvement during follow-up in Behçet’s syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F451675

Successful use of canakinumab in a patient with resistant Behçet's disease

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Colchicine versus placebo in Behçet's disease: randomized, double-blind, controlled crossover trial.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Resistant Behçet disease responsive to anakinra

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Successful treatment of severe Behçet's disease with infliximab in an Italian Olympic athlete.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Colchicine and benzathine penicillin in the treatment of Behçet disease: a case comparative study.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

[Adamantiades-Behçet disease. Therapeutic administration of systemic recombinant interferon-alpha-2a].

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4491584

Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study

28 November 2018

1 reference

12 December 2020

Successful treatment of resistant Behçet's disease with etanercept

1 reference

12 December 2020

Treatment of Behçet's disease with thalidomide

1 reference

12 December 2020

Thalidomide in the treatment of Behçet's syndrome

1 reference

12 December 2020

Remission induction in a case of refractory Behçet disease with alemtuzumab

1 reference

12 December 2020

Long-term effects of interferon alpha 2A treatment in Behçet's disease

1 reference

12 December 2020

Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?

1 reference

12 December 2020

Treatment of Adamantiades-Behçet disease with systemic interferon alfa

1 reference

12 December 2020

Interferon therapy for Behçet's disease

1 reference

12 December 2020

Vascular involvement in Behçet's syndrome: a retrospective analysis of associations and the time course

1 reference

12 December 2020

Cytokines in Behçet's disease

1 reference

12 December 2020

Production of TNF-alpha and IL-1 in active Behçet's disease

1 reference

12 December 2020

A double blind study of colchicine in Behçet's disease

1 reference

12 December 2020

Immunological effects of macrolides

1 reference

12 December 2020

Interferon-alpha treatment of Behçet's disease

1 reference

12 December 2020

Efficacy of cyclosporine on mucocutaneous manifestations of Behçet's disease

1 reference

12 December 2020

Suppression of Behçet's disease with dapsone

1 reference

12 December 2020

Regulation of TH17 and regulatory T cells in patients with Behçet disease

1 reference

12 December 2020

Streptococcal infection in the pathogenesis of Behçet's disease and clinical effects of minocycline on the disease symptoms

1 reference

12 December 2020

[Treatment of recurrent ulceration with low doses of thalidomide. Pilot study in 17 patients]

1 reference

12 December 2020